[1] | FN Tiruneh, KY Chuang, PAM Ntenda, YC Chuang. (2017). Individual-level and community-level determinants of cervical cancer screening among Kenyan women: a multilevel analysis of a Nationwide survey BMC Womens Health. 17: 109. doi: 10.1186/s12905-017-0469-9. |
[2] | PE Jolly, S Mthethwa-Hleta, LA Padilla, J Pettis, S Winston, TF Akinyemiju, HJ Turner, A Ejiawoko, R Brooks, L Preko, PO Preko. (2017). Screening, prevalence, and risk factors for cervical lesions among HIV positive and HIV negative women in Swaziland. BMC Public Health. 17: 218. doi: 10.1186/s12889-017-4120-3. |
[3] | A Bardají, C Mindu, OJ Augusto, A Casellas, O Cambaco, E Simbine, G Matsinhe, E Macete, C Menéndez, E Sevene, K Munguambe. (2018). Awareness of cervical cancer and willingness to be vaccinated against human papillomavirus in Mozambican adolescent girls. Papillomavirus Res. Jun; 5: 156–162. doi: 10.1016/j.pvr.2018.04.004. |
[4] | R Mlange, M Matovelo, P Rambau, B Kidenya. (2016). Patient and disease characteristics associated with late tumour stage at presentation of cervical cancer in northwestern Tanzania. BMC Womens Health. 16: 5. doi: 10.1186/s12905-016-0285-7. |
[5] | EL Haile, S Cindy, B Ina, G Belay, JP Van geertruyden, S Ransom, L Lebelo Ramokone, JP Bogers (2019). HPV testing on vaginal/cervical nurse-assisted self-samples versus clinician-taken specimens and the HPV prevalence, in Adama Town, Ethiopia. Medicine (Baltimore) Aug; 98(35): e16970. doi: 10.1097/MD.0000000000016970. |
[6] | T.G. Ginindza, X Dlamini, M Almonte, R Herrero, P.E. Jolly, J.M. Tsoka-Gwegweni, E. Weiderpass, N. Broutet, B. Sartorius. (2017). Prevalence of and Associated Risk Factors for High Risk Human Papillomavirus among Sexually Active Women, Swaziland. PLoS One. 12(1): e0170189. doi: 10.1371/journal.pone.0170189. |
[7] | FG Loubanou Tchibinda, ALM Boumba, E Ebatetou-Ataboho, G Loubano-Voumbi, AJC Thouassa, D Moukassa. (2019). Evaluation de la concentration plasmatique de l’il7 au cours de l’infection a hpv chez les femmes ayant le cancer du col de l’uterus au Congo. Annale des Sciences de la Santé 2019; 19. |
[8] | G Liu, M Sharma, N Tan, R Barnabas. (2018). HIV-positive women have higher risk of HPV infection, precancerous lesions, and cervical cancer: A systematic review and meta-analysis. AIDS. Author manuscript; available in PMC 2019 Mar 27. AIDS.27; 32(6): 795–808. doi: 10.1097/QAD.0000000000001765. |
[9] | Z Ndizeye, D Vanden Broeck, RL Lebelo, J Bogers, B Ina, JP Van Geertruyden. (2019). Prevalence and genotype-specific distribution of human papillomavirus in Burundi according to HIV status and urban or rural residence and its implications for control. PLoS One. 14(6): e0209303. doi: 10.1371/journal.pone.0209303. |
[10] | S Menon, A Wusiman, MC Boily, M Kariisa, H Mabeya, S Luchters, F Forland, R Rossi, S Callens, D vanden Broeck (2016). Epidemiology of HPV Genotypes among HIV Positive Women in Kenya: A Systematic Review and Meta-Analysis. PLoS One. 11(10): e0163965. doi: 10.1371/journal.pone.0163965. |
[11] | A Ermel, D Ramogola-Masire, N Zetola, Y Tong, B Qadadri, MM Azar. (2014), Brown DR. Invasive cervical cancers from women living in the United States or Botswana: differences in human papillomavirus type distribution. Infect Agent Cancer. 9: 22. doi: 10.1186/1750-9378-9-22. |
[12] | H De Vuyst, P Gichangi, B Estambale, E Njuguna, S Franceschi, M Temmerman. (2008). Human papillomavirus types in women with invasive cervical carcinoma by HIV status in Kenya. Int J Cancer. 122: 244–6. doi: 10.1002/ijc.23045. |
[13] | MF Baay, EF Kjetland, PD Ndhlovu, V Deschoolmeester, T Mduluza, E Gomo, H Friis, N Midzi, L Gwanzura, PR Mason, JB Vermorken, SG Gundersen.(2004). Human papillomavirus in a rural community in Zimbabwe: the impact of HIV co-infection on HPV genotype distribution. J Med Virol. 73(3): 481-5. |
[14] | H Kelly, HA Weiss, Y Benavente, S De Sanjose, P Mayaud, Art, et al. (2018). Association of antiretroviral therapy with high-risk human papillomavirus, cervical intraepithelial neoplasia, and invasive cervical cancer in women living with HIV: a systematic review and meta-analysis. Lancet HIV. 5(1): e45–e58. 10.1016/S2352-3018(17)30149-2. |
[15] | LJP Liebenberg, LR McKinnon, N Yende-Zuma, N Garrett N, C Baxter, ABM Kharsany, D Archary, A Rositch, N Samsunder, LE Mansoor, JAS Passmore, SS Abdool Karim, Q Abdool Karim.(2019). HPV infection and the genital cytokine milieu in women at high risk of HIV acquisition. Nat Commun. 10: 5227. doi: 10.1038/s41467-019-13089-2. |
[16] | JM McGregor, CA Harwood, L Brooks, et al. (2002). Relationship between p53 codon 72 polymorphism and susceptibility to sunburn and skin cancer. J Invest Dermatol, 119, 84-90. |
[17] | E. Alamartine, P Berthoux, C Mariat, et al. (2003). Interleukin-10 promoter polymorphisms and susceptibility to skin squamous cell carcinoma after renal transplantation. J Invest Dermatol 120, 99-103. 18. |
[18] | TB Tumer, D Yilmaz, C Tanrikut, et al. (2010). DNA repair XRCC1 Arg399Gln polymorphism alone, and in combination with CYP2E1 polymorphisms significantly contribute to the risk of development of childhood acute lymphoblastic leukemia. Leuk Res, 34, 1275- 1281. |
[19] | CH. White, B. Moesker, N. Beliakova-Bethell, LJ. Martins, CA. Spina, DM. Margolis, DD. Richman, V. Planelles, A. Bosque, CH. Woelk. (2016). Transcriptomic Analysis. Implicates the p53 Signaling Pathway in the Establishment of HIV-1 Latency in Central Memory CD4 T Cells in an In Vitro Model. PLoS Pathog. 12(11): e1006026. |
[20] | C-H Yoon, S-Y Kim, SE Byeon, Y Jeong, J Lee, KP Kim, J Park, Y-S Bae (2015). p53-Derived Host Restriction of HIV-1 Replication by Protein Kinase R-Mediated Tat Phosphorylation and Inactivation. J Virol.; 89(8): 4262–4280. |
[21] | W Mbuya, R Mcharo, J Mhizde, J Mnkai, A Mahenge, M Mwakatima, W Mwalongo, N Chiwerengo, M Hölscher, T Lennemann, E Saathoff, F Rwegoshora, L Torres, A Kroidl, C Geldmacher, K Held, Mkunde Chachage. (2020). Depletion and activation of mucosal CD4 T cells in HIV infected women with HPV-associated lesions of the cervix uterin. PLoS One. 15(10): e0240154. doi: 10.1371/journal.pone.0240154. |
[22] | B Autran, G Carcelain, TS Li, C Blanc, D Mathez, R Tubiana, et al. (1997). Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease. Science. 4; 277(5322): 112–6. 10.1126/science.277.5322.112. |
[23] | L Bruni, M Diaz, X Castellsagué, E Ferrer, FX Bosch, S De Sanjosé. (2010). Cervical human papillomavirus prevalence in 5 continents: meta-analysis of 1 million women with normal cytological findings. J Infect Dis. 15; 202(12): 1789-99. |
[24] | D Forman, C De Martel, CJ Lacey, I Soerjomataram, J Lortet-Tieulent, L Bruni, J Vignat, J Ferlay, F Bray, M Plummer, S Franceschi. (2012). Global burden of human papillomavirus and related diseases. Vaccine. 20; 30 Suppl 5(): F12-23. |
[25] | S De Sanjosé, M Diaz, X Castellsagué, G Clifford, L Bruni, N Muñoz, FX Bosch. (2007). Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis. Lancet Infect Dis.; 7(7): 453-9. |